Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HALO Precision Diagnostics operates commercial outpatient centers offering integrated precision diagnostic services. Their approach combines advanced imaging (MRI/CT), genomics/genetic testing, digital pathology, proteomics/biomarker analysis and AI-driven analytics to enable early detection of cancers (notably prostate and breast), cardiovascular disease and neurodegenerative disorders. They report serving over one million patients with rapid turnaround times for actionable results that guide individualized care plans. The company also offers minimally invasive treatments such as TULSA-Pro laser focal therapy for prostate cancer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HALO Precision Diagnostics.